Last updated 2026-07-20
- Acquired by Lyell Immunopharma for $93.7M, Oct 2024
Total raised
—
Last: Grant 2024-02
Stage
Acquired
Founded
2017
Headcount
108
HQ
Camarillo, United States
Sector
Health Tech & Life Sciences
About
ImmPACT Bio is a clinical-stage company dedicated to the discovery of transformative chimeric antigen receptor (CAR) T-cell therapies for cancer patients who have exhausted their treatment options. The company's logic-gate-based CAR T platforms address key biological challenges in treating cancer, specifically designed to prevent antigen escape, 'on-target - off-tumor' toxicities, and overcome the immunosuppressive tumor microenvironment. The company's technologies are based on the work of pioneering scientists Yvonne Chen, Ph.D., and Antoni Ribas, M.D., Ph.D., both from UCLA, and Gideon Gross, Ph.D., from the MIGAL-Galilee Research Institute.
Headcount over time
108 employees (2026-09) · 1 point
Offices
Camarillo, United States · HQ / main office
Show all offices (1 more)
- Los Angeles, United States
Q&A
- What is ImmPACT Bio's primary focus?
- ImmPACT Bio is a clinical-stage company dedicated to the discovery of transformative chimeric antigen receptor (CAR) T-cell therapies for cancer patients.
- When was ImmPACT Bio acquired and by whom?
- ImmPACT Bio was acquired by Lyell Immunopharma in October 2024.
- How much funding has ImmPACT Bio raised in total?
- ImmPACT Bio has raised a total of $137,000,000.
- When was ImmPACT Bio founded?
- ImmPACT Bio was founded in November 2016.
- What was ImmPACT Bio's most recent funding round?
- In February 2024, ImmPACT Bio received an $8,000,000 grant from the California Institute for Regenerative Medicine (CIRM).
- Which investors participated in ImmPACT Bio's $111,000,000 funding round in January 2022?
- The January 2022 funding round was led by venBio, with participation from OrbiMed.
- How many employees does ImmPACT Bio have?
- ImmPACT Bio has 11-50 employees.
- Where is ImmPACT Bio's headquarters located?
- ImmPACT Bio's headquarters is located in Rehovot, Israel, with an additional office in Los Angeles, USA.
Team · 7
Sumant Ramachandra
President and CEO
Rick Kendall
Chief Scientific Officer
Sheila Gujrathi
Chairperson of the Board
Erez Chimovits
Board Member
Avishai Levy
Board Member
Orna Harel
Board Member
Adi
Director of Research and Head of the Israeli site
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
biotechnologybiopharmaceuticallife-sciencesgenetic-engineeringmedical-technologiescancer-therapyhospitalshealthcare-providersoncologycell-therapycancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | immpact-bio.com/ |
|---|---|
| linkedin.com/company/37527946 |
Identifiers & details
| Legal name | ImmPACT Bio USA Inc. |
|---|---|
| Founded | 2017-4 |
| Employees (exact) | 108 |
| Offices | Los Angeles |
| Status reason | Acquired by Lyell Immunopharma on Oct 2024 |
Acquisitions & public offerings
Acquired by Lyell Immunopharma 2024-10 $93.7M
Radar intelligence
Patents
| EPO | 8 |
|---|
Web history (Wayback)
| Domain | immpact-bio.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515549004 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2016-11-16 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 3 — violation (1), annual_report (1), people (1) |
| Registered address | ריבלין יוסף 22 ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |
| 2026-06-07 | דו~ח שנתי |
| 2025-11-06 | עדכון בעלי תפקידים |